Retention and expansion for B2B SaaS founders for healthcare and life sciences in the Benelux region

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Benelux region. In this market, Benelux buyers reward multilingual specificity and a pitch that respects local nuance, so the way you install retention and expansion has to be shaped to that reality from day one.

If you are a B2B SaaS founder still under $5m ARR, retention and expansion is not something you delegate on day one. It is keeping and growing the customers you already paid to acquire, and until it works you cannot describe your business without hand-waving.

The founder value in retention and expansion is that one point of NRR is worth more than five points of new logo growth. You bring context no hire can replicate — the reason you started the company, the exact objection you heard on call number seven, the phrase a customer used that finally clicked.

Own the strategy, the first 30 live cycles, and the weekly review. Delegate the tooling, the list building, and the reporting. Founders who invert that order end up hiring around a broken model.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Benelux region it is compounded by the fact that local nuance and language fit, not scale is what actually gates growth. Retention and expansion is only useful here when it is pointed at both constraints at once.

Instrument gross and net revenue retention from day one — even if the number is embarrassing. You cannot debug what you do not measure, and every board meeting after Series A will start with this chart.

The founder trap in retention and expansion is treating CS as a support cost centre. It always looks reasonable at the time. Write the trap on a sticky note and stick it on your monitor.

The moment to hand off retention and expansion is when you can predict the number two weeks out and defend the assumptions behind it. Not before. VP hires that arrive earlier tend to leave inside 14 months.

Founders who take retention and expansion seriously in year one write category-defining companies in year three. The compounding is that stark.

Concretely for healthcare and life sciences in the Benelux region: the healthcare teams that install this get past procurement instead of dying in it, and one anchored Benelux customer becomes the reference the rest of the region asks for. That is the reason it is worth installing retention and expansion deliberately for this market rather than importing a playbook designed for somewhere else.